- Headquarters
- Seongnam, South Korea · East Asia
- Value chain
- Medicines & vaccines(Products); also Contract manufacturing
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 2018
- Ownership
- Listed
- Listing
- KRX:302440 on Google Finance
- Website
- skbioscience.com
- Relevance
- Low at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
In 2 capabilities
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Manufacture · listed #29 of 50
Developed SKYCovione, Korea's first domestic COVID-19 vaccine (with GSK adjuvant and University of Washington design), and is a CEPI partner for rapid-response vaccines.
Relevance: Korean vaccine developer
Biotechnology & Health Technologies · Manufacture · listed #35 of 50
Korea's leading vaccine manufacturer with the Andong L House plant, which produced Novavax and AstraZeneca COVID vaccines and its own SKYCovione.
Relevance: Korean vaccine manufacturer